Ledger.Open graph →
SEC Form D · Amendment · filed August 12, 2015

Genoa Pharmaceuticals, Inc

Offering
$2.2M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Michael J. Kamdar · San Diego, CADirectorMark W. Surber, Ph.D · San Diego, CAExec · DirectorRichard G. Vincent · San Diego, CAExecDaniel D. Burgess · San Diego, CADirectorRobert L. Fransen · MINNEAPOLIS, MNDirectorDavid Judelson · San Diego, CAExecBilly G. Sitton · Houston, TXDirectorTripp J. Keber · DENVER, COExec · DirectorIsaac Dietrich · DENVER, CODirectorEan J. Seeb · DENVER, CODirectorDaniel C. Hunt · DENVER, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗